Pregled bibliografske jedinice broj: 266844
Immunogenetic profile of late onset psoriasis
Immunogenetic profile of late onset psoriasis // Abstracts of 3rd Italian-Croatian Symposium on Psoriasis
Trst: Organizing and Scientific Secretariat of Symposium, 2006. (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 266844 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Immunogenetic profile of late onset psoriasis
Autori
Pasić, Aida ; Grahovac, Blaženka ; Lipozenčić, Jasna ; Čeović, Romana ; Kostović, Krešimir
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of 3rd Italian-Croatian Symposium on Psoriasis
/ - Trst : Organizing and Scientific Secretariat of Symposium, 2006
Skup
3rd Italian-Croatian Symposium on Psoriasis
Mjesto i datum
Trst, Italija, 22.09.2006
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
late-onse psoriasis; immunogenetic features
Sažetak
Psoriasis vulgaris has been subclassified according to age of onset. Early-onset psoriasis (also referred to as type I) has the onset before age 40, with a peak onset at age 16-22, and accounts for 70% of all psoriatics. Late-onset psoriasis (LOP), also termed type II psoriasis, shows the onset at or after age 40, with a peak onset at age 57-60. Although these forms of psoriasis cannot be distinguished on clinical and histopathological grounds, a distinct pattern of HLA associations has been reported. So, in early-onset psoriasis which also displays a strong family history, strong associations with class I alleles and specifically HLA-Cw6 have been observed. The aims of the study were to identify the immunogenetic features of late-onset psoriasis as a clinical entity, and to compare LOP and psoriasis vulgaris (PV) according to their immunogenetic profiles. Twenty-eight LOP patients were typed for HLA class I and class II.Control group consisted of 190 unrelated healthy blood donors and patients with psoriasis type I.In psoriasis type I, there was a significantly higher frequency of HLA alleles B13 (OR=8.89), B 57 (OR=9.34), Cw*06 (OR=12.78), DQB1*0701 (OR=9.70), DQA1*0201 (OR=4.92) and DQB1* 0303 (OR=53.89). In psoriasis type II, the frequency of HLA alleles did not differ significantly from that in control group.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA